Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation

Clinical trial NCT00861627 · COMPLETED

Trial details

NCT number: NCT00861627
Sponsor: Oncolytics Biotech
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-small Cell Lung

Start date: 2009-03-01
Primary completion: 2015-09-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.